CMI-1203
- Generic Name
- CMI-1203
A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.
- First Posted Date
- 2022-12-19
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 48
- Registration Number
- NCT05656274
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath